1.65TWD
143.94 MTWD
4.59 BTWD
40.91 M
About ORIENT EUROPHARMA CO
Sector
CEO
Mon Lin Tsai
Headquarters
Taipei
Website
Founded
1982
FIGI
BBG000BNXGT3
Orient Europharma Co. Ltd. engages in the manufacturing and trading of western medicine, health food and cosmetics. The company was founded in 1982 and is headquartered in Taipei, Taiwan.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 4120 is 42.20 TWD — it has increased by 2.30% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on TPEX exchange ORIENT EUROPHARMA CO stocks are traded under the ticker 4120.
4120 stock is 3.88% volatile and has beta coefficient of 0.43. Check out the list of the most volatile stocks — is ORIENT EUROPHARMA CO there?
Yes, you can track ORIENT EUROPHARMA CO financials in yearly and quarterly reports right on TradingView.
4120 stock has risen by 1.44% compared to the previous week, the month change is a 0.82% fall, over the last year ORIENT EUROPHARMA CO has showed a 16.25% increase.
4120 net income for the last quarter is 339.94 M TWD, while the quarter before that showed −34.77 M TWD of net income which accounts for 1.08 K% change. Track more ORIENT EUROPHARMA CO financial stats to get the full picture.
Today ORIENT EUROPHARMA CO has the market capitalization of 3.66 B, it has decreased by 2.41% over the last week.
Like other stocks, 4120 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ORIENT EUROPHARMA CO stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ORIENT EUROPHARMA CO technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ORIENT EUROPHARMA CO stock shows the neutral signal. See more of ORIENT EUROPHARMA CO technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ORIENT EUROPHARMA CO EBITDA is 286.88 M TWD, and current EBITDA margin is 6.25%. See more stats in ORIENT EUROPHARMA CO financial statements.